Terns Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $342k | 46k | 7.51 |
| 2025-06-30 | $170k | 46k | 3.73 |
| 2025-03-31 | $60k | 22k | 2.76 |
| 2024-12-31 | $242k | 44k | 5.54 |
| 2024-09-30 | $286k | 34k | 8.34 |
| 2024-06-30 | $233k | 34k | 6.81 |
| 2023-12-31 | $150k | 23k | 6.49 |
| 2023-09-30 | $116k | 23k | 5.03 |
| 2023-06-30 | $202k | 23k | 8.75 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors